Amman, Hadisa .

HRN: 23-20-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
CEFUROXIME 500MG (TAB)
09/26/2025
10/03/2025
PO
500 Mg
BID
S/P NSVD With RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines